Holden Medical Laboratories

What Holden Medical Laboratories does

Holden Medical Laboratories Pvt. Ltd. is an Indian pharmaceutical formulation company founded in 1997 as a joint venture between Mr. Nick Zee of Holland and Mr. Sandeep Joshi of India. The company develops, manufactures, and commercializes generic equivalents of innovator oral solid dosage products (OSD) - tablets, capsules, and granules - across therapeutic categories including antibacterial, anti-hypertensives, anthelmintics, anti-diabetics, and gastrointestinal treatments. Manufacturing is conducted at a WHO GMP-certified facility in Malegaon MIDC, Nashik, Maharashtra, supported by in-house formulation development, ICH stability testing, and bioequivalence study capability, plus a quality control laboratory equipped with HPLC, FTIR, UV-visible spectrophotometers, and dissolution apparatus.

The company maintains a portfolio of 103 pharmaceutical SKUs distributed across nine sub-brands and extends into adjacent verticals through its wholly-owned Holdenmed subsidiary, which covers veterinary pharmaceuticals, animal wellness, and pet food distribution. Revenue is generated B2B through export-driven distribution to international pharmaceutical distributors and healthcare procurement organizations across 25+ countries and all continents, with regional partners co-developing market-specific products. GTM operates through channel partners and enterprise field sales with no direct consumer marketing.

Holden is accredited under WHO GMP, CDSCO, ISO 9001, ISO 14001, OSHA 45001, and GLP frameworks, supporting regulatory access across multiple jurisdictions. The company remains privately held under founder-family control with no disclosed institutional funding, M&A, or public-listing activity. Strategic direction over the last decade has emphasized geographic broadening (notably the 2018 expansion into Europe and Asia, including an R&D facility investment) and vertical diversification into animal care and pet food, while maintaining a founder-led, low-headcount operating model.

Name

Holden Medical Laboratories

Legal name

Holden Medical Laboratories Pvt. Ltd.

Website

https://holdenlabindia.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

Holden Medical Laboratories is an India-based generic pharmaceutical manufacturer founded in 1997 as an India-Dutch joint venture, producing WHO GMP-certified oral solid dosage products (tablets, capsules, granules) across multiple therapeutic categories for export to 25+ countries.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

Keywords

• Generic pharmaceuticals manufacturing
• Oral solid dosage forms
• Pharmaceutical contract manufacturing
• Veterinary pharmaceutical products
• WHO GMP certified facility

Headquarters

HQ city

Thane

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and commercializing generic pharmaceutical products for export markets. The company develops, manufactures, and sells generic equivalents of innovator pharmaceutical products across multiple therapeutic categories to global markets.
2. Global Export: Export-focused business model supplying pharmaceutical products to over 25 countries across all continents. Revenue generated through direct sales to international pharmaceutical distributors and healthcare procurement organizations.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Holden Medical Laboratories develops, manufactures, and exports generic pharmaceutical oral solid dosage forms (tablets, capsules, and granules) across therapeutic categories including antibiotics, antidiabetics, antihypertensives, anthelmintics, and gastrointestinal drugs. The company also produces animal care products (Holdenmed brand) and pet food. Operations are anchored in a WHO GMP certified facility in Nashik, India, with products sold through B2B distribution channels to over 25 countries globally.

Product overview

Holden Medical Laboratories operates as a pharmaceutical formulation company offering a diversified portfolio of products across three main categories: human pharmaceuticals (oral solid dosage forms including tablets, capsules, and granules), animal care products, and pet food. The company develops and manufactures generic equivalents of innovator pharmaceutical products across therapeutic areas including antibiotics, antidiabetics, antihypertensives, gastrointestinal drugs, antihistamines, NSAIDs, and cardiovascular agents. Products are sold under various brand names such as Aziron, Epihold, Erycare, Dibehold, Progen, and Hitcold, with exports to over 25 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Holdenmed: Animal care brand focusing on veterinary pharmaceuticals and wellness products for animals
• Aziron
• Azihold
• Progen
• Dibehold
• Glibencare
• Epihold
• Holdamide
• Ibuden
• Hitcold
• Gengra
• Erycare

Products and services

• Generic Pharmaceuticals (Oral Solid Dosage Forms) Oral solid dosage pharmaceutical products (tablets, capsules, granules) covering antibiotics, antidiabetics, antihypertensives, gastrointestinal, antihistamines, NSAIDs, and cardiovascular agents, sold B2B to international pharmaceutical distributors and healthcare procurement organizations.
• Animal Care Products (Holdenmed) Range of animal care products including veterinary pharmaceuticals and wellness products designed for animal health and well-being, supporting veterinarians, farmers, and pet owners.
• Pet Food High-quality, nutritious pet food products with scientifically formulated nutrition for various life stages of pets.
• Aziron (Azithromycin Tablets) Azithromycin tablet antibiotic available in 250mg strength for treating bacterial infections.
• Epihold (Carbamazepine Tablets) Anticonvulsant medication for epilepsy management, available in 200mg strength.
• Erycare (Erythromycin Tablets) Erythromycin antibiotic tablet available in 250mg strength for bacterial infection treatment.
• Dibehold (Metformin Tablets) Metformin tablet for diabetes management, available in 500mg and 850mg strengths.
• Progen (Ciprofloxacin Tablets) Ciprofloxacin antibiotic tablet available in 250mg and 500mg strengths for treating bacterial infections.
• Hitcold (Paracetamol Combination Tablets) Combination cold medication containing Paracetamol, Chlorpheniramine maleate, and Caffeine.

Quantifiable outcome

• Products exported to over 25 countries globally
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• India & Dutch Joint Venture (Mr. Nick Zee from Holland)coreStrategic or Co-development Partner · 1 January 1997Holden Medical Laboratories was established as an India & Dutch joint venture in 1997 by Mr. Nick Zee from Holland and Mr. Sandeep Joshi from India. Both founders wanted to develop, manufacture, and commercialize generic pharmaceuticals focusing on quality and affordability. This joint venture brought together international expertise and Indian manufacturing capabilities.

Scale indicators4 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• Ipca Laboratories: Mid-sized Indian generic pharma with focus on anti-infectives, anti-malarials, and pain management OSDs, exporting to global markets including developing economies — a closely comparable size and product mix.
• Hikal: India-based pharmaceutical and animal health manufacturer with WHO GMP facilities producing APIs and finished formulations, exporting globally — comparable in size band and in combining human pharma with animal health.
• Unichem Laboratories: Indian generic manufacturer specializing in OSD formulations across cardiovascular, gastro, and anti-infective categories with export business; similar scale band and product overlap to Holden.
• Glenmark Pharmaceuticals: India-based generic and specialty pharma with significant emerging-market presence in OSD generics; similar therapeutic breadth and export-driven model make it a closer-size comparator than the top-tier players.
• Granules India: Indian pharma company focused on OSD formulations including paracetamol, metformin, and other high-volume generics, with significant global API and finished-dose exports — a relevant small-to-mid scale comparator.
• Alkem Laboratories: Indian generic manufacturer with strong OSD portfolio across anti-infectives, gastro, and cardio segments and meaningful export business — comparable mid-scale generic exporter profile.

Broad incumbents

• Sun Pharmaceutical Industries: India's largest specialty generic pharma company with extensive global operations across OSDs and other dosage forms; competes for the same tender and distributor relationships in developing markets.
• Lupin Pharmaceuticals: Indian-headquartered generic manufacturer with a strong emerging-markets export franchise across oral solids, comparable regulatory footprint, and similar therapeutic mix including anti-infectives and cardiometabolics.
• Cipla: One of India's largest generic pharmaceutical manufacturers with a broad OSD portfolio and extensive global export footprint, including emerging markets — directly comparable business model but at vastly greater scale.
• Aurobindo Pharma: Major Indian generic manufacturer producing tablets, capsules, and injectables for over 150 countries, with strong WHO GMP compliance and emerging-market focus — a much larger direct comparator for Holden's generic OSD export model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/holdenlab

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Holden Medical Laboratories